- Home
- KZR vs CHSCN Comparison
KZR vs CHSCN Comparison
Compare KZR & CHSCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZR
- CHSCN
- Stock Information
- Founded
- KZR 2015
- CHSCN N/A
- Country
- KZR United States
- CHSCN United States
- Employees
- KZR N/A
- CHSCN N/A
- Industry
- KZR Biotechnology: Pharmaceutical Preparations
- CHSCN Farming/Seeds/Milling
- Sector
- KZR Health Care
- CHSCN Industrials
- Exchange
- KZR Nasdaq
- CHSCN Nasdaq
- Market Cap
- KZR 29.7M
- CHSCN N/A
- IPO Year
- KZR 2018
- CHSCN N/A
- Fundamental
- Price
- KZR $3.86
- CHSCN $25.44
- Analyst Decision
- KZR Hold
- CHSCN
- Analyst Count
- KZR 2
- CHSCN 0
- Target Price
- KZR $9.00
- CHSCN N/A
- AVG Volume (30 Days)
- KZR 35.9K
- CHSCN N/A
- Earning Date
- KZR 11-11-2025
- CHSCN N/A
- Dividend Yield
- KZR N/A
- CHSCN N/A
- EPS Growth
- KZR N/A
- CHSCN N/A
- EPS
- KZR N/A
- CHSCN N/A
- Revenue
- KZR N/A
- CHSCN N/A
- Revenue This Year
- KZR N/A
- CHSCN N/A
- Revenue Next Year
- KZR N/A
- CHSCN N/A
- P/E Ratio
- KZR N/A
- CHSCN N/A
- Revenue Growth
- KZR N/A
- CHSCN N/A
- 52 Week Low
- KZR $3.62
- CHSCN N/A
- 52 Week High
- KZR $9.18
- CHSCN N/A
- Technical
- Relative Strength Index (RSI)
- KZR 41.41
- CHSCN 50.29
- Support Level
- KZR $3.76
- CHSCN $25.33
- Resistance Level
- KZR $4.09
- CHSCN $25.78
- Average True Range (ATR)
- KZR 0.14
- CHSCN 0.15
- MACD
- KZR 0.01
- CHSCN -0.02
- Stochastic Oscillator
- KZR 25.46
- CHSCN 34.71
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
About CHSCN CHS Inc Preferred Class B Series 2 Reset Rate
CHS Inc is an integrated agricultural enterprise, that provides grain, food, and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Geographically, the company derives maximum revenue from North America and the rest from South America, Asia Pacific, Europe, Middle East, and Africa (EMEA).